Recruiting
Neoplasm
RecruitingStudy of ALE.
InvestigationalNo placebo
Study of ALE.
InvestigationalNo placebo
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:ALE.P03
- Sponsor:Alentis Therapeutics AG
Back to the NetherlandsClinical trials in Delft – page 14
1 232 clinical trials in Delft, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Delft at a glance
1 232
clinical trials
- Research sites1
Recruiting
Calculus urinary
RecruitingA Study Testing Erector Spinae Plane Block with Ropivacaine versus Placebo for Pain Relief in Adults with Acute Kidney Stone Pain in the Emergency Department
Registered drug
A Study Testing Erector Spinae Plane Block with Ropivacaine versus Placebo for Pain Relief in Adults with Acute Kidney Stone Pain in the Emergency Department
Registered drug
- Disease:Calculus urinary
- Substances:Potassium ChlorideSodium Chloride+2
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Potassium Chloride
- Sponsor:Leids Universitair Medisch Centrum (LUMC)
Recruiting
Non-small cell lung cancer
RecruitingA Study Comparing PF-08046054 to Docetaxel in Adults with Previously Treated PD-L1 Positive Non-Small Cell Lung Cancer
Registered drugNo placebo
A Study Comparing PF-08046054 to Docetaxel in Adults with Previously Treated PD-L1 Positive Non-Small Cell Lung Cancer
Registered drugNo placebo
- Disease:Non-small cell lung cancer
- Substances:DocetaxelFetrastobart vedotin
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Docetaxel
- Sponsor:Pfizer Inc.
Recruiting
Study of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk
Registered drugNo placebo
Study of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk
Registered drugNo placebo
- Disease:Hormone receptor positive HER2 negative breast cancer
- Substances:AnastrozoleCyclophosphamide+11
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Anastrozole
- Sponsor:Unicancer
Recruiting
Hormone-refractory prostate cancer
RecruitingA Study of JNJ-78278343 Compared to Placebo for Patients with Advanced Prostate Cancer That No Longer Responds to Hormone Treatment
Investigational
A Study of JNJ-78278343 Compared to Placebo for Patients with Advanced Prostate Cancer That No Longer Responds to Hormone Treatment
Investigational
- Disease:Hormone-refractory prostate cancer
- Substances:JNJ-78278343
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:JNJ-78278343
- Sponsor:Janssen Cilag International
Recruiting
Atrial fibrillation
RecruitingA Study to Test How Well PKN605 Works and How Safe It Is in Patients with Atrial Fibrillation
Investigational
A Study to Test How Well PKN605 Works and How Safe It Is in Patients with Atrial Fibrillation
Investigational
- Disease:Atrial fibrillation
- Substances:PKN605
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:PKN605
- Sponsor:Novartis Pharma AG
Recruiting
Chronic obstructive pulmonary disease
RecruitingA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
Registered drug
A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
Registered drug
- Disease:Chronic obstructive pulmonary disease
- Substances:DepemokimabSalbutamol Sulfate
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Depemokimab
- Sponsor:Glaxosmithkline Research & Development Limited
Recruiting
Diabetes mellitus
RecruitingA Study of Teplizumab Compared to Placebo for Blood Sugar Control in Children and Young Adults Aged 1 to 25 Years with Newly Diagnosed Type 1 Diabetes
Investigational
A Study of Teplizumab Compared to Placebo for Blood Sugar Control in Children and Young Adults Aged 1 to 25 Years with Newly Diagnosed Type 1 Diabetes
Investigational
- Disease:Diabetes mellitus
- Substances:Teplizumab
Countries:The Netherlands
The Netherlands- Participants:0–17 years · 18–64 years
- Substances:Teplizumab
- Sponsor:Sanofi-Aventis Recherche & Developpement
Recruiting
Cholangiocarcinoma
RecruitingStudy of gemcitabine, cisplatin, and pembrolizumab before and after surgery compared to surgery alone for patients with bile duct cancer
Registered drugNo placebo
Study of gemcitabine, cisplatin, and pembrolizumab before and after surgery compared to surgery alone for patients with bile duct cancer
Registered drugNo placebo
- Disease:Cholangiocarcinoma
- Substances:CisplatinGemcitabine+1
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Cisplatin
- Sponsor:Amsterdam UMC Stichting
Recruiting
Hypertrophic cardiomyopathy+1
RecruitingA study testing ninerafaxstat compared to placebo in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
Investigational
A study testing ninerafaxstat compared to placebo in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
Investigational
- Disease:Hypertrophic cardiomyopathyCardiomyopathy
- Substances:Ninerafaxstat trihydrochloride monohydrate
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Ninerafaxstat trihydrochloride monohydrate
- Sponsor:Imbria Pharmaceuticals Inc.
Recruiting
Transplant rejection+1
RecruitingA Study of Belimumab to Help Identify Safe Kidney Transplant Matches in Patients with High Antibody Levels Against Donor Tissue Types
Registered drugNo placebo
A Study of Belimumab to Help Identify Safe Kidney Transplant Matches in Patients with High Antibody Levels Against Donor Tissue Types
Registered drugNo placebo
- Disease:Transplant rejectionAnti-HLA antibody test positive
- Substances:Belimumab
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Belimumab
- Sponsor:Leids Universitair Medisch Centrum (LUMC)
Recruiting
Beta haemolytic streptococcal infection
RecruitingA Study of Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine in Healthy Pregnant Women and Their Infants
Investigational
A Study of Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine in Healthy Pregnant Women and Their Infants
Investigational
- Disease:Beta haemolytic streptococcal infection
- Substances:GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE IB CONJUGATED TO DIPHTHERIA TOXIN CRM197STREPTOCOCCUS AGALACTIAE, SEROTYPE IA, CAPSULAR POLYSACCHARIDE, CONJUGATED TO CRM197+4
Countries:The Netherlands
The Netherlands- Participants:0–17 years · 18–64 years · Healthy volunteers
- Substances:GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE IB CONJUGATED TO DIPHTHERIA TOXIN CRM197
- Sponsor:Pfizer Inc.
Other cities in the Netherlands
The busiest research cities in the country
Clinical research in Delft
What the registry says about research in the country
01 Cardiovascular Research
Clinical trials focusing on cardiovascular disease management and prevention, including studies of novel treatments for atherosclerotic cardiovascular disease and innovative therapies targeting lipoprotein reduction.
- Lipid Management Studies
- Cardiovascular Risk Prevention
- Major Adverse Cardiac Events
Research exploring both established and experimental treatments to reduce cardiovascular complications and improve patient outcomes.
02 Oncology Studies
Comprehensive research into various cancer types, with significant focus on prostate cancer, breast cancer, and blood cancers including chronic lymphocytic leukemia.
- Advanced Imaging Techniques
- Targeted Therapies
- Treatment Combinations
Innovative approaches combining established treatments with novel therapeutic agents to enhance treatment effectiveness.
03 Women's Health
Studies addressing various aspects of women's health, including infertility treatments and management of uterine fibroids.
- Reproductive Health
- Gynecological Conditions
- Quality of Life Studies
Research comparing different treatment modalities and their impact on patient outcomes and quality of life.